Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06883994 · ClinicalTrials.gov registry record · NA
Fermented Vegetables and Gut Microbiome Pilot Study
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT06883994: Completed NA study, sponsored by USDA, Western Human Nutrition Research Center.
NCT06883994 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06883994, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the effect of fermented vegetable consumption on LAB abundance and tolerability of the intervention in young healthy people before conducting a full RCT with older participants.
Primary Outcome
Bacterial DNA extracted from subject stools will be used for quantitative polymerase chain reaction (qPCR) analysis using primers specific for lactic acid bacteria (LAB) in the intervention food, to estimate bacterial cell count per gram of wet stool.
Interventions
- OTHER Fermented vegetable intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2025-09-09 |
| Phase | NA |
What the finished NCT06883994 record still lists
NCT06883994 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Fermented vegetable intervention is the first listed.
NCT06883994 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06883994 about?
NCT06883994 is a clinical study titled "Fermented Vegetables and Gut Microbiome Pilot Study". The purpose of this research is to determine the effect of fermented vegetable consumption on LAB abundance and tolerability of the intervention in young healthy people before conducting a full RCT with older participants.
What is the current status of trial NCT06883994?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2025-03-19. Estimated completion is 2025-09-09.
What interventions are being tested in trial NCT06883994?
The interventions under investigation include: Fermented vegetable intervention (OTHER).
Who is sponsoring clinical trial NCT06883994?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06883994's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI